Purpose Recent reports of individuals with cytoplasmic transfer RNA (tRNA) synthetase-related disorders have identified cases with phenotypic variability from the index presentations. We sought to assess phenotypic variability in individuals with AARS1-related disease. Methods A cross-sectional survey was performed on individuals with biallelic variants in AARS1. Clinical data, neuroimaging, and genetic testing results were reviewed. Alanyl tRNA synthetase (AlaRS) activity was measured in available fibroblasts. Results We identified 11 affected individuals. Two phenotypic presentations emerged, one with early infantile–onset disease resembling the index cases of AARS1-related epileptic encephalopathy with deficient myelination (n = 7). The second (n = 4) was a later-onset disorder, where disease onset occurred after the first year of life and was characterized on neuroimaging by a progressive posterior predominant leukoencephalopathy evolving to include the frontal white matter. AlaRS activity was significantly reduced in five affected individuals with both early infantile–onset and late-onset phenotypes. Conclusion We suggest that variants in AARS1 result in a broader clinical spectrum than previously appreciated. The predominant form results in early infantile–onset disease with epileptic encephalopathy and deficient myelination. However, a subgroup of affected individuals manifests with late-onset disease and similarly rapid progressive clinical decline. Longitudinal imaging and clinical follow-up will be valuable in understanding factors affecting disease progression and outcome.

Expanded phenotype of AARS1-related white matter disease / Helman, G; Mendes, Mi; Nicita, F; Darbelli, L; Sherbini, O; Moore, T; Derksen, A; Amy, Pizzino; Carrozzo, R; Torraco, A; Catteruccia, M; Aiello, C; Goffrini, P; Figuccia, S; Smith, Dec; Hadzsiev, K; Hahn, A; Biskup, S; Brösse, I; Kotzaeridou, U; Gauck, D; Grebe, Ta; Elmslie, F; Stals, K; Gupta, R; Bertini, E; Thiffault, I; Taft, Rj; Schiffmann, R; Brandl, U; Haack, Tb; Salomons, Gs; Simons, C; Bernard, G; van der Knaap, Ms; Vanderver, A; Husain, Ra.. - In: GENETICS IN MEDICINE. - ISSN 1098-3600. - 23:12(2021), pp. 2352-2359. [10.1038/s41436-021-01286-8]

Expanded phenotype of AARS1-related white matter disease.

Goffrini P;Figuccia S;
2021

Abstract

Purpose Recent reports of individuals with cytoplasmic transfer RNA (tRNA) synthetase-related disorders have identified cases with phenotypic variability from the index presentations. We sought to assess phenotypic variability in individuals with AARS1-related disease. Methods A cross-sectional survey was performed on individuals with biallelic variants in AARS1. Clinical data, neuroimaging, and genetic testing results were reviewed. Alanyl tRNA synthetase (AlaRS) activity was measured in available fibroblasts. Results We identified 11 affected individuals. Two phenotypic presentations emerged, one with early infantile–onset disease resembling the index cases of AARS1-related epileptic encephalopathy with deficient myelination (n = 7). The second (n = 4) was a later-onset disorder, where disease onset occurred after the first year of life and was characterized on neuroimaging by a progressive posterior predominant leukoencephalopathy evolving to include the frontal white matter. AlaRS activity was significantly reduced in five affected individuals with both early infantile–onset and late-onset phenotypes. Conclusion We suggest that variants in AARS1 result in a broader clinical spectrum than previously appreciated. The predominant form results in early infantile–onset disease with epileptic encephalopathy and deficient myelination. However, a subgroup of affected individuals manifests with late-onset disease and similarly rapid progressive clinical decline. Longitudinal imaging and clinical follow-up will be valuable in understanding factors affecting disease progression and outcome.
Expanded phenotype of AARS1-related white matter disease / Helman, G; Mendes, Mi; Nicita, F; Darbelli, L; Sherbini, O; Moore, T; Derksen, A; Amy, Pizzino; Carrozzo, R; Torraco, A; Catteruccia, M; Aiello, C; Goffrini, P; Figuccia, S; Smith, Dec; Hadzsiev, K; Hahn, A; Biskup, S; Brösse, I; Kotzaeridou, U; Gauck, D; Grebe, Ta; Elmslie, F; Stals, K; Gupta, R; Bertini, E; Thiffault, I; Taft, Rj; Schiffmann, R; Brandl, U; Haack, Tb; Salomons, Gs; Simons, C; Bernard, G; van der Knaap, Ms; Vanderver, A; Husain, Ra.. - In: GENETICS IN MEDICINE. - ISSN 1098-3600. - 23:12(2021), pp. 2352-2359. [10.1038/s41436-021-01286-8]
File in questo prodotto:
File Dimensione Formato  
2101_AARS_MainText.v15.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 244.54 kB
Formato Adobe PDF
244.54 kB Adobe PDF Visualizza/Apri
2101_AARS_FIGURES.pdf

accesso aperto

Descrizione: Immagini
Tipologia: Altro materiale allegato
Licenza: Creative commons
Dimensione 7.71 MB
Formato Adobe PDF
7.71 MB Adobe PDF Visualizza/Apri
2101_AARS_SuppText.vsubmission.pdf

accesso aperto

Descrizione: Supplemento
Tipologia: Altro materiale allegato
Licenza: Creative commons
Dimensione 1.08 MB
Formato Adobe PDF
1.08 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2912781
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact